| ²é¿´: 286 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
yasima½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÇóÖúÁ½ÆªÓ¢ÎÄҽѧÎÄÏ×
|
||
|
1. ÌâÄ¿£º Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review. ×÷Õߣº Perrott J, Mabasa VH, Ensom MH. ÆÚ¿¯£º Ann Pharmacother. 2010 Mar; 44(3):557-64. Epub 2010 Feb 2. 2.ÌâÄ¿£ºPharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers ×÷ÕߣºCirillo I, Vaccaro N, Turner K, Solanki B, Natarajan J, Redman R. ÆÚ¿¯£ºJ Clin Pharmacol. 2009 Jul; 49(7):798-806. ҪȫÎÄ£¬ÏÖÔÚÖ»ÕÒµ½ÕªÒª£¬Ð»Ð»£¡xincailiao08@126.com |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÖØÇì´óѧ085404£¬×Ü·Ö314·Ö£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Êý¶þÓ¢¶þ348Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
»¯Ñ§µ÷¼ÁÇóÖú
ÒѾÓÐ3È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ѧ˶288µ÷¼Á!!!
ÒѾÓÐ3È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ5È˻ظ´
11408,335·Ö£¬±¾¿Æ211£¬Çóµ÷¼Á£¬¿Éתרҵ
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ7È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´

heitaoliu
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
~Áù~
- ²©Ñ§EPI: 11
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ¹ó±ö: 4.56
- ½ð±Ò: 54715.2
- É¢½ð: 14927
- ºì»¨: 91
- ɳ·¢: 14
- Ìû×Ó: 8614
- ÔÚÏß: 1149.6Сʱ
- ³æºÅ: 709015
- ×¢²á: 2009-02-26
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
- ¹ÜϽ: ÎÄÏ×ÇóÖú
yasima(½ð±Ò+20, ²©Ñ§EPI+1): ºÜºÃ ллÄã ½ð±Ò¶¼¸øÄãÁË ÄãÔÚÄÄÀïÕÒµÄÄØ 2010-07-22 17:53:57
| ÒÑÓÊÏäÀ² |

2Â¥2010-07-22 17:14:47














»Ø¸´´ËÂ¥